NTRA Jul 2024 92.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:10PM EDT. Market open.
| Previous close | 16.21 |
| Open | 16.21 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 92.50 |
| Expiry date | 2024-07-19 |
| Day's range | 16.21 - 16.21 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireNatera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
AUSTIN, Texas, May 23, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).
Business WireNatera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
AUSTIN, Texas, May 23, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4, 2024.
GuruFocus.comInsider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
On May 15, 2024, Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), executed a sale of 6,779 shares of the company.
© 2024 Yahoo. All rights reserved.